Europe Lags on Alzheimer’s Treatment Access

Europe faces a growing crisis regarding access to Alzheimer’s treatments due to its aging population and slower adoption of early intervention strategies compared to other parts of the world. While breakthroughs in therapies exist globally, many European countries are failing to provide reimbursement or implement necessary pathways, leaving patients and families without access to potentially life-changing care. This disparity highlights a critical need for systemic reform and investment to address the escalating burden of dementia across the continent.

Summarized from the sources above. Read the originals for the full story.